top of page
< Back

Umeclidinium

烏美溴銨

Mechanism of action:

Umeclidinium 是一種抗毒蕈鹼型乙醯膽鹼受體的支氣管擴張劑(muscarinic acetylcholine receptor antagonist),屬於季銨類(quaternary ammonium)化合物。Umeclidinium 能選擇性拮抗支氣管平滑肌上的毒蕈鹼型乙醯膽鹼受體(muscarinic acetylcholine receptor),特別是 M₃ 受體(Gq/11 蛋白偶聯受體),阻止乙醯膽鹼(acetylcholine)的作用,使細胞質鈣離子濃度下降,讓支氣管平滑肌放鬆。

​Reference(s):

1. Feldman GJ et al. (2013). The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects. Ther Adv Respir Dis. 


2. Decramer M et al. (2013). Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients. Respir Physiol Neurobiol.

bottom of page